Explore ›
Finding
Finding
null
There was no difference in the primary outcome between verapamil SR-based and atenolol-based treatment strategies for any age group, including the very old.
| Effect size | No difference (Figure 4) |
| Comparator | Atenolol-based antihypertensive strategy |
| Effect summary | null; No difference (Figure 4) |
| Effect modifiers | [{"modifier": "age group", "interaction_p": "", "direction": "null", "stratum_details": "No difference in outcomes by treatment strategy in any age group (<60, 60-<70, 70-<80, >=80)", "plain_language": "Whether your doctor chooses a calcium channel blocker or beta-blocker strategy doesn't matter for outcomes, regardless of your age", "annotation_notes": "Both strategies achieved very similar blood pressure control across all age groups."}] |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC3008373
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy